Kevin Joseph Fitzgerald Alnylam Pharmaceuticals, Inc. (ALNY) insider trading activity

Kevin Joseph Fitzgerald is CSO & EVP, Head of Research of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 12,881 shares of ALNY, which is worth approximately $3.43 Million. The most recent transaction as insider was on Aug 12, 2024, when has been sold 22,025 shares (Common Stock) at a price of $271.83 per share, resulting in proceeds of $5,987,055. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.9K

9.17% 3M change

n/a 12M change

Total Value Held $3.43 Million

Kevin Joseph Fitzgerald Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 12 2024	SELL Open market or private sale	$5,987,055 $271.83 p/Share	22,025 Reduced 63.1%	12,881 Common Stock
Aug 12 2024	BUY Exercise of conversion of derivative security	$1,893,436 $91.36 p/Share	20,725 Added 37.25%	34,906 Common Stock
Jun 25 2024	SELL Open market or private sale	$274,845 $229.42 p/Share	1,198 Reduced 7.79%	14,181 Common Stock
Jun 24 2024	BUY Grant, award, or other acquisition	-	2,498 Added 13.97%	15,379 Common Stock

Also insider at

OVID

Ovid Therapeutics Inc. Healthcare

Director

KJF